LEADER 01561oam  2200505   450 
001 9910715192703321
005 20220405143119.0
035   $a(CKB)5470000002508083
035   $a(OCoLC)1225937608$z(OCoLC)1231540937
035   $a(EXLCZ)995470000002508083
100   $a20201207d2020      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCreating Hope Reauthorization Act $ereport (to accompany H.R. 4439)
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d[2020]
215   $a1 online resource (11 pages)
225 1 $aReport / 116th Congress, 2d session, House of Representatives ;$v116-551
300   $a"September 29, 2020."
320   $aIncludes bibliographical references.
517   $aCreating Hope Reauthorization Act 
606   $aRare diseases$zUnited States
606   $aChildren$xDiseases$zUnited States
606   $aDrugs$xLaw and legislation$zUnited States
608   $aLegislative materials.$2lcgft
608   $aDocuments le?gislatifs.$2rvmgf
615  0$aRare diseases
615  0$aChildren$xDiseases
615  0$aDrugs$xLaw and legislation
676   $a1.1/8:116-551
801  0$bGPO
801  1$bGPO
801  2$bOCLCO
801  2$bOCLCF
801  2$bDWP
801  2$bGPO
801  2$bOCLCQ
801  2$bGPO
801  2$bOCLCO
906   $aBOOK
912   $a9910715192703321
996   $aCreating Hope Reauthorization Act$93474411
997   $aUNINA